ALX Oncology Reports Aspen-03 and Aspen-04 Phase 2 Trials Evaluating Evorpacept With a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

U.S. Effective Federal Funds Rate at 4.33 Pct on 24 April on $103 Bln in Trades Vs 4.33 Pct on $107 Bln on 23 April - Fed Data

Russian C.bank Governor Nabiullina: Rate Increase Possibility This Year Has Diminished